Juno Therapeutics, Inc.
Seattle, United States · Founded 2013
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Juno Therapeutics, Inc was founded in 2013 by Anthony J. Evnin, Steven Harr, Richard J. Klausner, Mark Frohlich, Robert J. Nelsen, Marc J. Tessier-Lavigne, Hal J. Barron, Hyam Levitsky, Howard J. Pien, Hans Bishop, Mary Agnes Wilderotter, Bernard J. Cassidy, Robert Azelby, Thomas Agnes Daniel, Rupert Agnes Vessey, Sunil Agarwal and Jay J. Flatley, and is based in Seattle, United States.
Key facts
- Industry
- Biotechnology
- Legal form
- Incorporated in Delaware
About
Biological Products, (No Diagnostic Substances); filing with the SEC since 2013
Founders
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director, Promoter
1500 Founder Rating
Executive Officer, Promoter
1500 Founder Rating
Director, Promoter
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer, Director, Promoter
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
Director
1500 Founder Rating
Executive Officer
1500 Founder Rating
Director
1500 Founder Rating
In context
We hold 1,386 other biotechnology companies founded in the 2010s. None has a closure on record yet. Of the 1,338 that report what they raised, the median is $4,000,000.
Counted across this directory, from founding and closing years in public records. Medians cover only companies whose closure is recorded; a company with no closure date may have quietly ceased without the record catching it.
Discussion
Log in to join the discussion and like comments.
Log In to Comment